University of California Davis Health Pediatric Rehabilitation Medicine

Topics

• Muscle Physiology and Disorders 150
• Spinal Cord Injury Research 22
• Neurogenetic and Muscular Disorders Research 15
• Cerebral Palsy and Movement Disorders 9
• Hereditary Neurological Disorders 5
• Spinal Dysraphism and Malformations 5
• Genetic Neurodegenerative Diseases 4
• Myasthenia Gravis and Thymoma 4
• Scoliosis diagnosis and treatment 4
• Nerve Injury and Rehabilitation 3
• Traumatic Brain Injury Research 3
• Amyotrophic Lateral Sclerosis Research 2

Most cited

1. AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.

   Nature medicine · 2025 · 143 citations · Craig McDonald

2. Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

   The Lancet. Neurology · 2024 · 113 citations · Craig McDonald

3. Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial.

   Neurology · 2024 · 70 citations · Craig McDonald

4. Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.

   JAMA · 2022 · 116 citations · Craig McDonald

5. Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.

   JAMA neurology · 2022 · 114 citations · Craig McDonald

6. Delandistrogene Moxeparvovec Gene Therapy in Ambulatory Patients (Aged ≥4 to <8 Years) with Duchenne Muscular Dystrophy: 1-Year Interim Results from Study SRP-9001-103 (ENDEAVOR).

   Annals of neurology · 2023 · 86 citations · Craig McDonald

7. Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial.

   JAMA network open · 2022 · 76 citations · Craig McDonald

8. Expression of SRP-9001 dystrophin and stabilization of motor function up to 2 years post-treatment with delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscular dystrophy.

   Frontiers in cell and developmental biology · 2023 · 71 citations · Craig McDonald